Document Detail


Predicting significant hyperbilirubinaemia and early discharge for glucose-6-phosphate dehydrogenase deficient newborns.
MedLine Citation:
PMID:  12772532     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: This study aims to assess the usefulness of day 3 (49 to 72 hours) pre-phototherapy total serum bilirubin (TSB) in predicting subsequent significant hyperbilirubinaemia (SHB) and the feasibility of early discharge for term and near-term glucose-6-phosphate dehydrogenase (G6PD) deficient newborns. MATERIALS AND METHODS: This prospective cohort study involved in born G6PD deficient neonates who were > or = 35 weeks and weighted > or = 2000 g at birth. TSB levels and phototherapy requirements in their first two weeks of life were studied. Day 3 pre-phototherapy TSB in the subgroup weighing > or = 2500 g at birth was analysed for its value in predicting subsequent SHB. RESULTS: Of the 129 neonates, 58 (45%) required phototherapy in the first week. Of these, only 4 patients (3.1%) needed phototherapy to be restarted in the second week. Seventy-one (55%) neonates did not require phototherapy at all. In the absence of SHB in the first week, the probability of its development in the second week was zero (95% confidence interval, 0 to 0.057). In the subgroup weighing > or = 2500 g at birth, day 3 pre-phototherapy TSB < or = 154 umol/L predicted no measurable risk of subsequent SHB (sensitivity, 100%; 95% confidence interval, 91.4% to 100%; negative predictive value, 100%; 95% confidence interval, 86.7% to 100%). CONCLUSIONS: G6PD deficient newborns without SHB in their first week of life were at no measurable risk of its development in the second week. Day 3 pre-phototherapy TSB in the subgroup weighing > or = 2500 g was useful for predicting the risk of subsequent SHB. Low-risk infants, thus identified, may be eligible for discharge on or before day 7 of life. Evidence-based early discharge can decrease the social and financial burden of G6PD deficiency in Singapore.
Authors:
H H Lim; L M Daniel; J Lee; M C Tan
Publication Detail:
Type:  Evaluation Studies; Journal Article    
Journal Detail:
Title:  Annals of the Academy of Medicine, Singapore     Volume:  32     ISSN:  0304-4602     ISO Abbreviation:  Ann. Acad. Med. Singap.     Publication Date:  2003 Mar 
Date Detail:
Created Date:  2003-05-29     Completed Date:  2003-10-07     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7503289     Medline TA:  Ann Acad Med Singapore     Country:  Singapore    
Other Details:
Languages:  eng     Pagination:  257-61     Citation Subset:  IM    
Affiliation:
Department of Neonatology, KK Women's and Children's Hospital.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Awards and Prizes
Bilirubin / blood*
Birth Weight
Cohort Studies
Female
Glucosephosphate Dehydrogenase / blood
Glucosephosphate Dehydrogenase Deficiency / blood,  epidemiology*
Humans
Incidence
Infant, Newborn
Jaundice, Neonatal / blood,  diagnosis*,  therapy
Male
Neonatal Screening
Patient Discharge
Phototherapy
Predictive Value of Tests
Prospective Studies
Sensitivity and Specificity
Singapore / epidemiology
Time Factors
Chemical
Reg. No./Substance:
635-65-4/Bilirubin; EC 1.1.1.49/Glucosephosphate Dehydrogenase
Comments/Corrections
Erratum In:
Ann Acad Med Singapore. 2003 Jul;32(4):570

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  7th Yahya Cohen Lecture. Significance of the lateral epiphysis of the acetabulum to hip joint stabil...
Next Document:  Runme Shaw Memorial Lecture 2002. Modern management of colorectal polyps: Are they all premalignant?